Tenderwize
Wróć do wyszukiwania

Drug Discount Agreements for Various Active Substances (Open-House)

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Jun 24, 2027 · 302 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...

No documented procurement documents analyzed; may contain additional obligations not covered in notice.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Supply of pharmaceutical products (discount agreements) for seven active substances: Budesonide (oral 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, Umeclidinium bromide.
  • Open-house model: any eligible pharmaceutical entrepreneur can join at any time during the contract period.
Pokaż pełne podsumowanie

The tender is an open-house procedure for drug discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for seven active substances: Budesonide (oral, 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, and Umeclidinium bromide. The buyer is AOK NordWest. The procedure is not a public procurement under EU directives (per EuGH C-410/14) but published voluntarily. The contract duration is up to 24 months starting 01.09.2025. All eligible pharmaceutical entrepreneurs can join at any time. No estimated value or award criteria are specified. Electronic submission is not allowed; applications are via email. The deadline for submission is 24.06.2027, 23:59 (but continuous accession is possible).

Ryzyka

Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...

No documented procurement documents analyzed; may contain additional obligations not covered in notice.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG for the offered medicinal products, throughout the contract duration.
  • Application via email to [email protected].

Administrative

  • Uniform contract conditions; no individual negotiations.

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Dortmund, DEU

Identyfikator

DE124159739

Działalność

Health

Części (1)

LOT-0001

Drug Discount Agreements for Various Active Substances (Open-House)

All eligible pharmaceutical entrepreneurs can conclude discount agreements for the listed active substances under uniform conditions. The contract runs max. 24 months from 01.09.2025. There is no exclusivity; the buyer may later award exclusive contracts that suspend these agreements.

SuppliesEU fundedElectronic submission

Lokalizacja

Hagen, Germany

Czas trwania

Aug 2025 - Aug 2027

Kategoria

Pharmaceutical products

Termin

Deadline Jun 24, 2027

Szczegóły zamówienia

Data publikacji
17 Jul 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
470057-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3